News Focus
News Focus
icon url

Roman516

12/12/22 7:30 AM

#547680 RE: HyGro #547660

JAMA does their homework!
JAMA does not take information from a given source on blind faith and publishes it
without doing their own DD.
The comment below is false and just an opinion
"JAMA Oncology only saw the post hoc protocol that was provided them. The post hoc SAP provided them. They were not given all the facts about the trial."
It is important to know the true and not allow false information to bias others, IMPO.
NWBO is on the right path and that is a fact.
icon url

SkyLimit2022

12/12/22 11:00 AM

#547741 RE: HyGro #547660

This is 100% verifiably false. It is documented and published. PFS and the original trial protocol were covered extensively in the independent peer review. Furthermore, the implications of pseudo-progression are well-documented in the documents submitted to the JAMA peer-review, and pseudo is well-documented in the medical literature in general.

If you want to learn about the original trial protocol all those years ago, consult JAMA and the peer review documents that JAMA has published and made available worldwide. The links are included on the DCVax-L P3 peer review page at the JAMA Oncology website linked below.

https://cdn.jamanetwork.com/ama/content_public/journal/oncology/0/coi220066supp1_prod_1668698380.81699.pdf?Expires=1673747242&Signature=YmWPqPQCKvIB7n9qa-xMmmbMuh1OHdpu-daeSIBdM1sIffk78vDecEbRLg6UMLjQySSjBRMj~9Vx1p~Ej1nZkkQgBWHAf7gUMhh62UbUZiRnB2wPtoWM-6lmiUBU6kS2IUwRwYbk0wYmHtP9txKnhi7xuNnY8m5w-maeKQOXwz~sBddSIvFxkwWnabPLZggvW9-KKAEoMihAjerpKD3UIzscEND5em5q0iYLo1f2bLN4Vbe7fx77zCTijhsp477oGyPNHKIhyAkRZsRI8BsZ8SyskxoMtJTmlQ6y95nSACd03PpABR84nWrJ1buJsOPetbh9FAMvOoioq7R-LRFLtA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA



https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847







Contact JAMA: jamaonc@jamanetwork.org



Bullish
Bullish